Assignee
PHAIM PHARMA LTD
GB·1 granted patent·8 pending applications·2 citations·filing 2019–2025
Top patents by PatentIndex Score
9 records- 0177US11286303B2CTLA4 fusion proteins for the treatment of diabetesPHAIM PHARMA LTD·Filed 2019·Granted Mar 29, 2022·2 cites·20 claims
- 0276US2023333094A1Diabetes BiomarkersPHAIM PHARMA LTD·Filed 2023·Application pending·0 cites
- 0374US2025237643A1Diabetes BiomarkersPHAIM PHARMA LTD·Filed 2025·Application pending·0 cites
- 0473US2024058442A1Combinations of Modalities for the Treatment of DiabetesPHAIM PHARMA LTD·Filed 2023·Application pending·0 cites
- 0561US2024316168A1Immunomodulatory Therapy For Type 1 Diabetes Mellitus AutoimmunityPHAIM PHARMA LTD·Filed 2024·Application pending·0 cites
- 0657US2024361217A1Psoriasis and Other Autoimmune Diseases Antigen Immune Modulator (AIM) Therapeutic PlatformPHAIM PHARMA LTD·Filed 2024·Application pending·0 cites
- 0749US2021353727A1Immunomodulatory therapy for type 1 diabetes mellitus autoimmunityPHAIM PHARMA LTD·Filed 2021·Application pending·0 cites
- 0845US2021404921A1Psoriasis and other autoimmune diseases antigen immune modulator (aim) therapeutic platformPHAIM PHARMA LTD·Filed 2021·Application pending·0 cites
- 0940US2024285732A1Patient Profiling for Antigen-Specific Immunomodulatory TherapiesPHAIM PHARMA LTD·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →